Search Results 1031-1040 of 16833 for Linaclotide

  1. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  2. [18F] Fluoroethyl-L-tyrosine PET/MRI for identifying small functional pituitary adenomas - Mayo Clinic

    About this study. The purpose of this research is to evaluate the diagnostic role and clinical efficacy of [18F]FET-PET/MRI in detecting MRI-occult primary ...

  3. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn. The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells ...

  4. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  5. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  6. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  7. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  8. Communities During COVID – Focus Groups - Mayo Clinic

    The study seeks to understand the impacts the COVID pandemic has brought to the communities, how communities are coping and how we can build resilience to ...

  9. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  10. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.